Disposables push Pall sales growth; Merck taps CMO Patheon for expanded services;

> Pall Life Sciences reports that third-quarter consumable sales to drugmakers grew 9 percent worldwide over third-quarter figures from a year ago, thanks in part to expanding adoption of single-use technologies. Item

> Contract manufacturer Patheon has expanded its services for Merck. Item

> Increased compliance requirements and pressure to achieve higher quality have resulted in new drug delivery options. Article

> ProximaRF and Phase IV Engineering have partnered to offer high-frequency RFID-enabled sensing products. Announcement

> Existing manufacturing facilities can be made smaller and more efficient by producing proteins in fermentors with Dyadic's C1 technology, a specialized fungus that can mass-produce enzymes and proteins. Article

Suggested Articles

Popular logic says you never switch horses, or CDMOs, in the middle of the stream, but Acacia Pharma had to do that to win an FDA approval.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

A warning letter says Chinese API maker Yibin Lihao Bio-technical was found lying to the FDA about manufacturing unapproved heparin.